SPIRONOLACTONE TEVA 100 MG

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

SPIRONOLACTONE

MAH:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC_code:

C03DA01

pharmaceutical_form:

TABLETS

composition:

SPIRONOLACTONE 100 MG

administration_route:

PER OS

prescription_type:

Required

manufactured_by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

therapeutic_group:

SPIRONOLACTONE

therapeutic_area:

SPIRONOLACTONE

therapeutic_indication:

Edematous conditions: congestive heart failure; cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. Essential hypertention. Primary hyperaldostronism. Hypokalemia.

authorization_date:

2011-11-30